% | $
Quotes you view appear here for quick access.

Rockwell Medical, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • bexho2000 bexho2000 Jul 9, 2008 12:18 PM Flag

    Moving Down to $5 or Up to $8????


    BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of dialysis products and services, today announced that it signed exclusive license agreements for the intravenous (IV) Iron products Venofer® (iron sucrose) and Ferinject® (ferric carboxymaltose) to treat iron deficiency anemia experienced by dialysis patients. Venofer® is the leading IV Iron product worldwide.

    The agreement concerns all commercialization activities for these IV Iron products in the field of dialysis and is expected to become effective not later than January 1st, 2009.

    As part of the 10-year Agreement for North America....

    RMTI's wonder drug toast????

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think you are missing the point of Rockwell's SFP. SFP is given with the dialysis treatment and provides low levels of iron to the bloodstream over time as opposed to single high doses like Venofere and Ferinject.

      Fresenius doesn't have the option to use SFP at this time since it hasn't been through clinical testing yet. Once it is proven out, who would not want to provide iron through dialysis if its CHEAPER to the dialysis provider and is more effective than other IV iron drugs? Effectiveness and cost will drive SFP in the marketplace if it proves out. Venofer may become completely obsolete.

    • SFP is not a drug. It is a natural way of introducing iron into the blood stream. These other additives you talk of often times have toxic side effects to the liver.

      There will always be a place for SFP in the dialysis market. A huge place when considering cost per patient and what is good for the patient.

      You can only imagine the battle that could very well now be going on right now for exclusive rights to SFP. Nothing surprises me any more.

9.14-0.19(-2.04%)1:11 PMEDT